1
|
Lee RC, Feinbaum RL and Ambros V: The C.
elegans heterochronic gene lin-4 encodes small RNAs with antisense
complementarity to lin-14. Cell. 75:843–854. 1993. View Article : Google Scholar : PubMed/NCBI
|
2
|
Wightman B, Ha I and Ruvkun G:
Posttranscriptional regulation of the heterochronic gene lin-14 by
lin-4 mediates temporal pattern formation in C. elegans. Cell.
75:855–862. 1993. View Article : Google Scholar : PubMed/NCBI
|
3
|
Bartel DP: MicroRNAs: Genomics,
biogenesis, mechanism and function. Cell. 116:281–297. 2004.
View Article : Google Scholar : PubMed/NCBI
|
4
|
Gidlöf O, Smith JG, Miyazu K, Gilje P,
Spencer A, Blomquist S and Erlinge D: Circulating cardio-enriched
microRNAs are associated with long-term prognosis following
myocardial infarction. BMC Cardiovasc Disord. 13:122013. View Article : Google Scholar : PubMed/NCBI
|
5
|
Marfella R, Di Filippo C, Potenza N, Sardu
C, Rizzo MR, Siniscalchi M, Musacchio E, Barbieri M, Mauro C, Mosca
N, et al: Circulating microRNA changes in heart failure patients
treated with cardiac resynchronization therapy: Responders vs.
Non-responders. Eur J Heart Fail. 15:1277–1288. 2013. View Article : Google Scholar : PubMed/NCBI
|
6
|
Ellis KL, Cameron VA, Troughton RW,
Frampton CM, Ellmers LJ and Richards AM: Circulating microRNAs as
candidate markers to distinguish heart failure in breathless
patients. Eur J Heart Fail. 15:1138–1147. 2013. View Article : Google Scholar : PubMed/NCBI
|
7
|
Asangani IA, Rasheed SA, Nikolova DA,
Leupold JH, Colburn NH, Post S and Allgayer H: MicroRNA-21 (miR-21)
post-transcriptionally downregulates tumor suppressor Pdcd4 and
stimulates invasion, intravasation and metastasis in colorectal
cancer. Oncogene. 27:2128–2136. 2008. View Article : Google Scholar : PubMed/NCBI
|
8
|
Selcuklu SD, Donoghue MT and Spillane C:
miR-21 as a key regulator of oncogenic processes. Biochem Soc
Trans. 37:918–925. 2009. View Article : Google Scholar : PubMed/NCBI
|
9
|
Suárez Y, Fernández-Hernando C, Pober JS
and Sessa WC: Dicer dependent microRNAs regulate gene expression
and functions in human endothelial cells. Circ Res. 100:1164–1173.
2007. View Article : Google Scholar : PubMed/NCBI
|
10
|
Ji R, Cheng Y, Yue J, Yang J, Liu X, Chen
H, Dean DB and Zhang C: MicroRNA expression signature and
antisense-mediated depletion reveal an essential role of MicroRNA
in vascular neointimal lesion formation. Circ Res. 100:1579–1588.
2007. View Article : Google Scholar : PubMed/NCBI
|
11
|
Roy S, Khanna S, Hussain SR, Biswas S,
Azad A, Rink C, Gnyawali S, Shilo S, Nuovo GJ and Sen CK: MicroRNA
expression in response to murine myocardial infarction: miR-21
regulates fibroblast metalloprotease-2 via phosphatase and tensin
homologue. Cardiovasc Res. 82:21–29. 2009. View Article : Google Scholar : PubMed/NCBI
|
12
|
Zhang C: MicroRNomics: A newly emerging
approach for disease biology. Physiol Genomics. 33:139–147. 2008.
View Article : Google Scholar : PubMed/NCBI
|
13
|
Cheng Y and Zhang C: MicroRNA-21 in
cardiovascular disease. J Cardiovasc Transl Res. 3:251–255. 2010.
View Article : Google Scholar : PubMed/NCBI
|
14
|
Dong S, Cheng Y, Yang J, Li J, Liu X, Wang
X, Wang D, Krall TJ, Delphin ES and Zhang C: MicroRNA expression
signature and the role of microRNA-21 in the early phase of acute
myocardial infarction. J Biol Chem. 284:29514–29525. 2009.
View Article : Google Scholar : PubMed/NCBI
|
15
|
Thum T, Gross C, Fiedler J, Fischer T,
Kissler S, Bussen M, Galuppo P, Just S, Rottbauer W, Frantz S, et
al: MicroRNA-21 contributes to myocardial disease by stimulating
MAP kinase signalling in fibroblasts. Nature. 456:980–984. 2008.
View Article : Google Scholar : PubMed/NCBI
|
16
|
Shepler SA and Patel AN: Cardiac cell
therapy: A treatment option for cardiomyopathy. Crit Care Nurs Q.
30:74–80. 2007. View Article : Google Scholar : PubMed/NCBI
|
17
|
Pruitt AL: Heart failure: It's not just
for men. Crit Care Nurs Clin North Am. 20:327–341. 2008. View Article : Google Scholar : PubMed/NCBI
|
18
|
Chiong M, Wang ZV, Pedrozo Z, Cao DJ,
Troncoso R, Ibacache M, Criollo A, Nemchenko A, Hill JA and
Lavandero S: Cardiomyocyte death: Mechanisms and translational
implications. Cell Death Dis. 2:e2442011. View Article : Google Scholar : PubMed/NCBI
|
19
|
Thum T, Galuppo P, Wolf C, Fiedler J,
Kneitz S, van Laake LW, Doevendans PA, Mummery CL, Borlak J,
Haverich A, et al: MicroRNAs in the human heart: A clue to fetal
gene reprogramming in heart failure. Circulation. 116:258–267.
2007. View Article : Google Scholar : PubMed/NCBI
|
20
|
Dong S, Ma W, Hao B, Hu F, Yan L, Yan X,
Wang Y, Chen Z and Wang Z: microRNA-21 promotes cardiac fibrosis
and development of heart failure with preserved left ventricular
ejection fraction by up-regulating Bcl-2. Int J Clin Exp Pathol.
7:565–574. 2014.PubMed/NCBI
|
21
|
Emerging Risk Factors Collaboration, . Di
Angelantonio E, Sarwar N, Perry P, Kaptoge S, Ray KK, Thompson A,
Wood AM, Lewington S, Sattar N, et al: Major lipids,
apolipoproteins, and risk of vascular disease. JAMA. 302:1993–2000.
2009. View Article : Google Scholar : PubMed/NCBI
|
22
|
van Holten TC, Waanders LF, de Groot PG,
Vissers J, Hoefer IE, Pasterkamp G, Prins MW and Roest M:
Circulating biomarkers for predicting cardiovascular disease risk;
a systematic review and comprehensive overview of meta-analyses.
PLoS One. 8:e620802013. View Article : Google Scholar : PubMed/NCBI
|
23
|
Rodseth RN, Buse GA Lurati, Bolliger D,
Burkhart CS, Cuthbertson BH, Gibson SC, Mahla E, Leibowitz DW and
Biccard BM: The predictive ability of pre-operative B-type
natriuretic peptide in vascular patients for major adverse cardiac
events: An individual patient data meta-analysis. J Am Coll
Cardiol. 58:522–529. 2011. View Article : Google Scholar : PubMed/NCBI
|
24
|
Liu L, Aguirre SA, Evering WE, Hirakawa
BP, May JR, Palacio K, Wang J, Zhang Y and Stevens GJ: miR-208a as
a biomarker of isoproterenol-induced cardiac injury in
Sod2+/− and C57BL/6J wild-type mice. Toxicol Pathol.
42:1117–1129. 2014. View Article : Google Scholar : PubMed/NCBI
|
25
|
Devaux Y, Vausort M, McCann GP, Zangrando
J, Kelly D, Razvi N, Zhang L, Ng LL, Wagner DR and Squire IB:
MicroRNA-150: A novel marker of left ventricular remodeling after
acute myocardial infarction. Circ Cardiovasc Genet. 6:290–298.
2013. View Article : Google Scholar : PubMed/NCBI
|
26
|
Olivieri F, Antonicelli R, Lorenzi M,
D'Alessandra Y, Lazzarini R, Santini G, Spazzafumo L, Lisa R, La
Sala L, Galeazzi R, et al: Diagnostic potential of circulating
miR-499-5p in elderly patients with acute non ST-elevation
myocardial infarction. Int J Cardiol. 167:531–536. 2013. View Article : Google Scholar : PubMed/NCBI
|
27
|
Zhang HL, Yang LF, Zhu Y, Yao XD, Zhang
SL, Dai B, Zhu YP, Shen YJ, Shi GH and Ye DW: Serum miRNA-21:
Elevated levels in patients with metastatic hormone-refractory
prostate cancer and potential predictive factor for the efficacy of
docetaxel-based chemotherapy. Prostate. 71:326–331. 2011.
View Article : Google Scholar : PubMed/NCBI
|
28
|
Wang ZX, Bian HB, Wang JR, Cheng ZX, Wang
KM and De W: Prognostic significance of serum miRNA-21 expression
in human non-small cell lung cancer. J Surg Oncol. 104:847–851.
2011. View Article : Google Scholar : PubMed/NCBI
|
29
|
McMurray JJ, Adamopoulos S, Anker SD,
Auricchio A, Böhm M, Dickstein K, Falk V, Filippatos G, Fonseca C,
Gomez-Sanchez MA, et al: ESC guidelines for the diagnosis and
treatment of acute and chronic heart failure 2012: The Task Force
for the Diagnosis and Treatment of Acute and Chronic Heart Failure
2012 of the European Society of Cardiology. Developed in
collaboration with the Heart Failure Association (HFA) of the ESC.
Eur J Heart Fail. 14:803–869. 2012. View Article : Google Scholar : PubMed/NCBI
|
30
|
Adnan M, Morton G and Hadi S: Analysis of
rpoS and bolA gene expression under various stress-induced
environments in planktonic and biofilm phase using 2(−ΔΔCT) method.
Mol Cell Biochem. 357:275–282. 2011. View Article : Google Scholar : PubMed/NCBI
|
31
|
Truong QA, Januzzi JL, Szymonifka J, Thai
WE, Wai B, Lavender Z, Sharma U, Sandoval RM, Grunau ZS, Basnet S,
et al: Coronary sinus biomarker sampling compared to peripheral
venous blood for predicting outcomes in patients with severe heart
failure undergoing cardiac resynchronization therapy: The BIOCRT
study. Heart Rhythm. 11:2167–2175. 2014. View Article : Google Scholar : PubMed/NCBI
|
32
|
Phelan D, Watson C, Martos R, Collier P,
Patle A, Donnelly S, Ledwidge M, Baugh J and McDonald K: Modest
elevation in BNP in asymptomatic hypertensive patients reflects
sub-clinical cardiac remodeling, inflammation and extracellular
matrix changes. PLoS One. 7:e492592012. View Article : Google Scholar : PubMed/NCBI
|
33
|
Luchner A, Stevens TL, Borgeson DD,
Redfield M, Wei CM, Porter JG and Burnett JC Jr: Differential
atrial and ventricular expression of myocardial BNP during
evolution of heart failure. Am J Physiol. 274:H1684–H1689.
1998.PubMed/NCBI
|
34
|
Olivieri F, Spazzafumo L, Santini G,
Lazzarini R, Albertini MC, Rippo MR, Galeazzi R, Abbatecola AM,
Marcheselli F, Monti D, et al: Age-related differences in the
expression of circulating microRNAs: miR-21 as a new circulating
marker of inflammaging. Mech Ageing Dev. 133:675–685. 2012.
View Article : Google Scholar : PubMed/NCBI
|
35
|
Olivieri F, Spazzafumo L, Bonafè M,
Recchioni R, Prattichizzo F, Marcheselli F, Micolucci L, Mensà E,
Giuliani A, Santini G, et al: MiR-21-5p and miR-126a-3p levels in
plasma and circulating angiogenic cells: Relationship with type 2
diabetes complications. Oncotarget. 6:35372–35382. 2015.PubMed/NCBI
|
36
|
Cardin S, Guasch E, Luo X, Naud P, Le
Quang K, Shi Y, Tardif JC, Comtois P and Nattel S: Role for
microRNA-21 in atrial profibrillatory fibrotic remodeling
associated with experimental postinfarction heart failure. Circ
Arrhythm Electrophysiol. 5:1027–1035. 2012. View Article : Google Scholar : PubMed/NCBI
|
37
|
Abraham WT, Fisher WG, Smith AL, Delurgio
DB, Leon AR, Loh E, Kocovic DZ, Packer M, Clavell AL, Hayes DL, et
al: Cardiac resynchronization in chronic heart failure. N Engl J
Med. 346:1845–1853. 2002. View Article : Google Scholar : PubMed/NCBI
|